Tag: BioCryst Pharmaceuticals

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to BioCryst Pharmaceuticals

Hereditary Angioedema Drugs Market Analysis by Current Industry Status & Growth Opportunities ...

Added to Collection on: 2021-04-02 06:13:25

Tags for this article:

Complement deficiency
Health care
Organ systems
Health sciences
Kinin–kallikrein system
Pharmaceuticals policy
Angioedema
Hereditary angioedema
C1-inhibitor
Bradykinin
Shire
BioCryst Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Analysts Expect BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) to Announce -$0.26 EPS

Added to Collection on: 2021-04-18 02:15:00

Tags for this article:

Financial ratios
Finance
Money
BioCryst Pharmaceuticals
Economy
Fundamental analysis
Corporate finance
Price?earnings ratio
Earnings per share
Short
BioCryst Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
$12.80 Million in Sales Expected for BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) This Quarter

Added to Collection on: 2021-04-18 02:20:35

Tags for this article:

Finance
Money
Economy
BioCryst Pharmaceuticals
Valuation
Stock market
Securities research
Short
Price?earnings ratio
Financial analyst
Stock
BioCryst Pharmaceuticals Inc.
Zacks

Click the tags to see associated articles and topics

View Article Details
Is BCRX Stock A Buy or Sell?

Added to Collection on: 2021-04-20 13:30:00

Tags for this article:

Finance
Investment
Hedge funds
Alternative investment management companies
NASDAQ
BioCryst Pharmaceuticals
Citadel LLC

Click the tags to see associated articles and topics

View Article Details
Zacks: Brokerages Expect BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Will Announce ...

Added to Collection on: 2021-05-05 05:26:15

Tags for this article:

BioCryst Pharmaceuticals
Life Sciences
Peramivir
Health care
Pharmaceutical industry in China
Biotechnology
BioCryst Pharmaceuticals Company
BioCryst Pharmaceuticals Inc.
Zacks

Click the tags to see associated articles and topics

View Article Details
JP Morgan bullish on six Big Biotechs, rates nine others neutral or lower (NASDAQ:INSM)

Added to Collection on: 2023-11-25 21:42:53

Tags for this article:

BioCryst Pharmaceuticals
NASDAQ
BIOCRYST PHARMACEUTICALS , INC

Click the tags to see associated articles and topics

View Article Details
BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) large institutional owners must be happy ...

Added to Collection on: 2025-02-01 13:54:17

Tags for this article:

Stock market
Institutional investors
BioCryst Pharmaceuticals
Alternative investment management companies
Equity securities
Private equity
Insider trading
Hedge fund
Stock
Dividend
BioCryst Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Insights 2025

Added to Collection on: 2025-05-29 18:28:51

Tags for this article:

Pharmaceutical companies
Swedish Orphan Biovitrum
Alnylam Pharmaceuticals
Amgen
BioCryst Pharmaceuticals
Novartis
Regeneron Pharmaceuticals
AstraZeneca
Roche
University of California, San Francisco
Pharmaceutical industry

Click the tags to see associated articles and topics

View Article Details
FDA approves Ionis' hereditary angioedema drug - BioPharma Dive

Added to Collection on: 2025-08-21 22:07:57

Tags for this article:

Complement deficiency
Hereditary angioedema
Serpinopathies
Angioedema
Ionis Pharmaceuticals
Ionis
BioCryst Pharmaceuticals
Medication
Sebetralstat

Click the tags to see associated articles and topics

View Article Details
Millennium Management LLC Has $28.60 Million Position in BioCryst Pharmaceuticals, Inc. $BCRX

Added to Collection on: 2025-09-14 08:37:44

Tags for this article:

BioCryst Pharmaceuticals
Peramivir
Stock
UBS
Millennium Management Llc

Click the tags to see associated articles and topics

View Article Details
Book a Demo